nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyrazinamide—AOX1—Methotrexate—psoriatic arthritis	0.511	0.561	CbGbCtD
Pyrazinamide—CYP3A4—Methylprednisolone—psoriatic arthritis	0.0992	0.109	CbGbCtD
Pyrazinamide—CYP3A4—Triamcinolone—psoriatic arthritis	0.0752	0.0825	CbGbCtD
Pyrazinamide—CYP3A4—Betamethasone—psoriatic arthritis	0.0645	0.0708	CbGbCtD
Pyrazinamide—CYP3A4—Prednisolone—psoriatic arthritis	0.0636	0.0698	CbGbCtD
Pyrazinamide—CYP3A4—Prednisone—psoriatic arthritis	0.0601	0.066	CbGbCtD
Pyrazinamide—CYP3A4—Dexamethasone—psoriatic arthritis	0.0375	0.0412	CbGbCtD
Pyrazinamide—Peptic ulcer—Prednisolone—psoriatic arthritis	0.00241	0.0271	CcSEcCtD
Pyrazinamide—Hepatomegaly—Prednisolone—psoriatic arthritis	0.00228	0.0256	CcSEcCtD
Pyrazinamide—Peptic ulcer—Triamcinolone—psoriatic arthritis	0.00222	0.0249	CcSEcCtD
Pyrazinamide—Peptic ulcer—Methylprednisolone—psoriatic arthritis	0.00222	0.0249	CcSEcCtD
Pyrazinamide—Hepatomegaly—Triamcinolone—psoriatic arthritis	0.0021	0.0236	CcSEcCtD
Pyrazinamide—Hepatomegaly—Methylprednisolone—psoriatic arthritis	0.00209	0.0235	CcSEcCtD
Pyrazinamide—Peptic ulcer—Dexamethasone—psoriatic arthritis	0.00201	0.0226	CcSEcCtD
Pyrazinamide—Peptic ulcer—Betamethasone—psoriatic arthritis	0.00201	0.0226	CcSEcCtD
Pyrazinamide—Hepatomegaly—Betamethasone—psoriatic arthritis	0.0019	0.0214	CcSEcCtD
Pyrazinamide—Hepatomegaly—Dexamethasone—psoriatic arthritis	0.0019	0.0214	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00177	0.0199	CcSEcCtD
Pyrazinamide—Peptic ulcer—Prednisone—psoriatic arthritis	0.00175	0.0197	CcSEcCtD
Pyrazinamide—Anorexia—Auranofin—psoriatic arthritis	0.00172	0.0193	CcSEcCtD
Pyrazinamide—Hepatomegaly—Prednisone—psoriatic arthritis	0.00166	0.0186	CcSEcCtD
Pyrazinamide—Dyspepsia—Auranofin—psoriatic arthritis	0.00159	0.0179	CcSEcCtD
Pyrazinamide—Decreased appetite—Auranofin—psoriatic arthritis	0.00157	0.0176	CcSEcCtD
Pyrazinamide—Urticaria—Auranofin—psoriatic arthritis	0.00143	0.0161	CcSEcCtD
Pyrazinamide—Pruritus—Auranofin—psoriatic arthritis	0.00128	0.0144	CcSEcCtD
Pyrazinamide—Hepatotoxicity—Methotrexate—psoriatic arthritis	0.00127	0.0143	CcSEcCtD
Pyrazinamide—Vomiting—Auranofin—psoriatic arthritis	0.00115	0.0129	CcSEcCtD
Pyrazinamide—Rash—Auranofin—psoriatic arthritis	0.00114	0.0128	CcSEcCtD
Pyrazinamide—Dermatitis—Auranofin—psoriatic arthritis	0.00114	0.0128	CcSEcCtD
Pyrazinamide—Nausea—Auranofin—psoriatic arthritis	0.00107	0.0121	CcSEcCtD
Pyrazinamide—Hyperuricaemia—Methotrexate—psoriatic arthritis	0.00106	0.0119	CcSEcCtD
Pyrazinamide—Blood uric acid increased—Methotrexate—psoriatic arthritis	0.000998	0.0112	CcSEcCtD
Pyrazinamide—Photosensitivity—Methotrexate—psoriatic arthritis	0.00081	0.00911	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Prednisolone—psoriatic arthritis	0.000655	0.00736	CcSEcCtD
Pyrazinamide—Malaise—Prednisolone—psoriatic arthritis	0.000636	0.00715	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Triamcinolone—psoriatic arthritis	0.000602	0.00676	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Methylprednisolone—psoriatic arthritis	0.000601	0.00675	CcSEcCtD
Pyrazinamide—Discomfort—Prednisolone—psoriatic arthritis	0.000593	0.00667	CcSEcCtD
Pyrazinamide—Malaise—Triamcinolone—psoriatic arthritis	0.000585	0.00657	CcSEcCtD
Pyrazinamide—Malaise—Methylprednisolone—psoriatic arthritis	0.000584	0.00656	CcSEcCtD
Pyrazinamide—Dysuria—Methotrexate—psoriatic arthritis	0.000575	0.00646	CcSEcCtD
Pyrazinamide—Photosensitivity reaction—Methotrexate—psoriatic arthritis	0.000561	0.00631	CcSEcCtD
Pyrazinamide—Myalgia—Triamcinolone—psoriatic arthritis	0.000552	0.00621	CcSEcCtD
Pyrazinamide—Myalgia—Methylprednisolone—psoriatic arthritis	0.000551	0.00619	CcSEcCtD
Pyrazinamide—Arthralgia—Methylprednisolone—psoriatic arthritis	0.000551	0.00619	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Betamethasone—psoriatic arthritis	0.000546	0.00614	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Dexamethasone—psoriatic arthritis	0.000546	0.00614	CcSEcCtD
Pyrazinamide—Discomfort—Triamcinolone—psoriatic arthritis	0.000546	0.00613	CcSEcCtD
Pyrazinamide—Discomfort—Methylprednisolone—psoriatic arthritis	0.000545	0.00612	CcSEcCtD
Pyrazinamide—Malaise—Betamethasone—psoriatic arthritis	0.000531	0.00597	CcSEcCtD
Pyrazinamide—Malaise—Dexamethasone—psoriatic arthritis	0.000531	0.00597	CcSEcCtD
Pyrazinamide—Myalgia—Dexamethasone—psoriatic arthritis	0.000501	0.00563	CcSEcCtD
Pyrazinamide—Myalgia—Betamethasone—psoriatic arthritis	0.000501	0.00563	CcSEcCtD
Pyrazinamide—Discomfort—Betamethasone—psoriatic arthritis	0.000495	0.00556	CcSEcCtD
Pyrazinamide—Discomfort—Dexamethasone—psoriatic arthritis	0.000495	0.00556	CcSEcCtD
Pyrazinamide—Hepatitis—Methotrexate—psoriatic arthritis	0.000492	0.00553	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.000482	0.00542	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.000481	0.00541	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Prednisone—psoriatic arthritis	0.000476	0.00535	CcSEcCtD
Pyrazinamide—Feeling abnormal—Prednisolone—psoriatic arthritis	0.000475	0.00533	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.00047	0.00529	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.00047	0.00529	CcSEcCtD
Pyrazinamide—Dyspepsia—Triamcinolone—psoriatic arthritis	0.000466	0.00524	CcSEcCtD
Pyrazinamide—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.000465	0.00523	CcSEcCtD
Pyrazinamide—Malaise—Prednisone—psoriatic arthritis	0.000462	0.0052	CcSEcCtD
Pyrazinamide—Anorexia—Dexamethasone—psoriatic arthritis	0.000458	0.00515	CcSEcCtD
Pyrazinamide—Anorexia—Betamethasone—psoriatic arthritis	0.000458	0.00515	CcSEcCtD
Pyrazinamide—Urticaria—Prednisolone—psoriatic arthritis	0.000457	0.00514	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.000438	0.00492	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.000438	0.00492	CcSEcCtD
Pyrazinamide—Myalgia—Prednisone—psoriatic arthritis	0.000436	0.0049	CcSEcCtD
Pyrazinamide—Arthralgia—Prednisone—psoriatic arthritis	0.000436	0.0049	CcSEcCtD
Pyrazinamide—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.000436	0.0049	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.000435	0.00489	CcSEcCtD
Pyrazinamide—Discomfort—Prednisone—psoriatic arthritis	0.000431	0.00485	CcSEcCtD
Pyrazinamide—Hypersensitivity—Prednisolone—psoriatic arthritis	0.000424	0.00477	CcSEcCtD
Pyrazinamide—Dyspepsia—Dexamethasone—psoriatic arthritis	0.000423	0.00475	CcSEcCtD
Pyrazinamide—Dyspepsia—Betamethasone—psoriatic arthritis	0.000423	0.00475	CcSEcCtD
Pyrazinamide—Urticaria—Triamcinolone—psoriatic arthritis	0.000421	0.00473	CcSEcCtD
Pyrazinamide—Urticaria—Methylprednisolone—psoriatic arthritis	0.00042	0.00472	CcSEcCtD
Pyrazinamide—Body temperature increased—Triamcinolone—psoriatic arthritis	0.000419	0.0047	CcSEcCtD
Pyrazinamide—Decreased appetite—Betamethasone—psoriatic arthritis	0.000418	0.00469	CcSEcCtD
Pyrazinamide—Decreased appetite—Dexamethasone—psoriatic arthritis	0.000418	0.00469	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.000415	0.00466	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.000415	0.00466	CcSEcCtD
Pyrazinamide—Anorexia—Prednisone—psoriatic arthritis	0.000399	0.00448	CcSEcCtD
Pyrazinamide—Ill-defined disorder—Methotrexate—psoriatic arthritis	0.000398	0.00447	CcSEcCtD
Pyrazinamide—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.000396	0.00445	CcSEcCtD
Pyrazinamide—Feeling abnormal—Betamethasone—psoriatic arthritis	0.000396	0.00445	CcSEcCtD
Pyrazinamide—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.00039	0.00438	CcSEcCtD
Pyrazinamide—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000389	0.00437	CcSEcCtD
Pyrazinamide—Malaise—Methotrexate—psoriatic arthritis	0.000386	0.00434	CcSEcCtD
Pyrazinamide—Urticaria—Dexamethasone—psoriatic arthritis	0.000382	0.00429	CcSEcCtD
Pyrazinamide—Urticaria—Betamethasone—psoriatic arthritis	0.000382	0.00429	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000381	0.00428	CcSEcCtD
Pyrazinamide—Body temperature increased—Dexamethasone—psoriatic arthritis	0.00038	0.00427	CcSEcCtD
Pyrazinamide—Body temperature increased—Betamethasone—psoriatic arthritis	0.00038	0.00427	CcSEcCtD
Pyrazinamide—Pruritus—Triamcinolone—psoriatic arthritis	0.000375	0.00421	CcSEcCtD
Pyrazinamide—Pruritus—Methylprednisolone—psoriatic arthritis	0.000374	0.0042	CcSEcCtD
Pyrazinamide—Dyspepsia—Prednisone—psoriatic arthritis	0.000368	0.00414	CcSEcCtD
Pyrazinamide—Arthralgia—Methotrexate—psoriatic arthritis	0.000365	0.0041	CcSEcCtD
Pyrazinamide—Myalgia—Methotrexate—psoriatic arthritis	0.000365	0.0041	CcSEcCtD
Pyrazinamide—Decreased appetite—Prednisone—psoriatic arthritis	0.000364	0.00409	CcSEcCtD
Pyrazinamide—Rash—Prednisolone—psoriatic arthritis	0.000363	0.00408	CcSEcCtD
Pyrazinamide—Dermatitis—Prednisolone—psoriatic arthritis	0.000363	0.00408	CcSEcCtD
Pyrazinamide—Discomfort—Methotrexate—psoriatic arthritis	0.00036	0.00405	CcSEcCtD
Pyrazinamide—Feeling abnormal—Prednisone—psoriatic arthritis	0.000345	0.00387	CcSEcCtD
Pyrazinamide—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000342	0.00385	CcSEcCtD
Pyrazinamide—Nausea—Prednisolone—psoriatic arthritis	0.000342	0.00384	CcSEcCtD
Pyrazinamide—Pruritus—Dexamethasone—psoriatic arthritis	0.00034	0.00382	CcSEcCtD
Pyrazinamide—Pruritus—Betamethasone—psoriatic arthritis	0.00034	0.00382	CcSEcCtD
Pyrazinamide—Vomiting—Triamcinolone—psoriatic arthritis	0.000337	0.00378	CcSEcCtD
Pyrazinamide—Vomiting—Methylprednisolone—psoriatic arthritis	0.000336	0.00377	CcSEcCtD
Pyrazinamide—Rash—Triamcinolone—psoriatic arthritis	0.000334	0.00375	CcSEcCtD
Pyrazinamide—Dermatitis—Triamcinolone—psoriatic arthritis	0.000334	0.00375	CcSEcCtD
Pyrazinamide—Anorexia—Methotrexate—psoriatic arthritis	0.000333	0.00375	CcSEcCtD
Pyrazinamide—Rash—Methylprednisolone—psoriatic arthritis	0.000333	0.00374	CcSEcCtD
Pyrazinamide—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000333	0.00374	CcSEcCtD
Pyrazinamide—Urticaria—Prednisone—psoriatic arthritis	0.000332	0.00374	CcSEcCtD
Pyrazinamide—Body temperature increased—Prednisone—psoriatic arthritis	0.000331	0.00372	CcSEcCtD
Pyrazinamide—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000319	0.00358	CcSEcCtD
Pyrazinamide—Nausea—Triamcinolone—psoriatic arthritis	0.000315	0.00353	CcSEcCtD
Pyrazinamide—Nausea—Methylprednisolone—psoriatic arthritis	0.000314	0.00353	CcSEcCtD
Pyrazinamide—Hypersensitivity—Prednisone—psoriatic arthritis	0.000308	0.00346	CcSEcCtD
Pyrazinamide—Dyspepsia—Methotrexate—psoriatic arthritis	0.000308	0.00346	CcSEcCtD
Pyrazinamide—Vomiting—Dexamethasone—psoriatic arthritis	0.000305	0.00343	CcSEcCtD
Pyrazinamide—Vomiting—Betamethasone—psoriatic arthritis	0.000305	0.00343	CcSEcCtD
Pyrazinamide—Decreased appetite—Methotrexate—psoriatic arthritis	0.000304	0.00342	CcSEcCtD
Pyrazinamide—Rash—Betamethasone—psoriatic arthritis	0.000303	0.0034	CcSEcCtD
Pyrazinamide—Rash—Dexamethasone—psoriatic arthritis	0.000303	0.0034	CcSEcCtD
Pyrazinamide—Dermatitis—Betamethasone—psoriatic arthritis	0.000303	0.0034	CcSEcCtD
Pyrazinamide—Dermatitis—Dexamethasone—psoriatic arthritis	0.000303	0.0034	CcSEcCtD
Pyrazinamide—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000302	0.00339	CcSEcCtD
Pyrazinamide—Pruritus—Prednisone—psoriatic arthritis	0.000296	0.00333	CcSEcCtD
Pyrazinamide—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000288	0.00324	CcSEcCtD
Pyrazinamide—Nausea—Betamethasone—psoriatic arthritis	0.000285	0.00321	CcSEcCtD
Pyrazinamide—Nausea—Dexamethasone—psoriatic arthritis	0.000285	0.00321	CcSEcCtD
Pyrazinamide—Urticaria—Methotrexate—psoriatic arthritis	0.000278	0.00312	CcSEcCtD
Pyrazinamide—Body temperature increased—Methotrexate—psoriatic arthritis	0.000276	0.00311	CcSEcCtD
Pyrazinamide—Vomiting—Prednisone—psoriatic arthritis	0.000266	0.00299	CcSEcCtD
Pyrazinamide—Rash—Prednisone—psoriatic arthritis	0.000264	0.00296	CcSEcCtD
Pyrazinamide—Dermatitis—Prednisone—psoriatic arthritis	0.000264	0.00296	CcSEcCtD
Pyrazinamide—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000258	0.0029	CcSEcCtD
Pyrazinamide—Nausea—Prednisone—psoriatic arthritis	0.000249	0.00279	CcSEcCtD
Pyrazinamide—Pruritus—Methotrexate—psoriatic arthritis	0.000247	0.00278	CcSEcCtD
Pyrazinamide—Vomiting—Methotrexate—psoriatic arthritis	0.000222	0.0025	CcSEcCtD
Pyrazinamide—Rash—Methotrexate—psoriatic arthritis	0.00022	0.00248	CcSEcCtD
Pyrazinamide—Dermatitis—Methotrexate—psoriatic arthritis	0.00022	0.00248	CcSEcCtD
Pyrazinamide—Nausea—Methotrexate—psoriatic arthritis	0.000208	0.00233	CcSEcCtD
